Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
View ORCID ProfileFien HR De Winter, View ORCID ProfileAn Hotterbeekx, Manon Huizing, View ORCID ProfileAngelina Konnova, View ORCID ProfileErik Fransen, View ORCID ProfileBart’s Jongers, Ravi Kumar Jairam, View ORCID ProfileVincent Van averbeke, View ORCID ProfilePieter Moons, View ORCID ProfileElla Roelant, View ORCID ProfileDebbie Le Blon, View ORCID ProfileWim Vanden Berghe, View ORCID ProfileAnnelies Janssens, View ORCID ProfileWillem Lybaert, View ORCID ProfileLieselot Croes, View ORCID ProfileChristof Vulsteke, View ORCID ProfileSurbhi Malhotra-Kumar, View ORCID ProfileHerman Goossens, View ORCID ProfileZwi Berneman, View ORCID ProfileMarc Peeters, View ORCID ProfilePeter van Dam, View ORCID ProfileSamir Kumar-Singh
doi: https://doi.org/10.1101/2021.10.29.21265511
Fien HR De Winter
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
An Hotterbeekx
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Manon Huizing
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
3Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
Angelina Konnova
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Erik Fransen
4StatUa, Center for Statistics, University of Antwerp, Antwerp, B-2000, Belgium
Bart’s Jongers
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Ravi Kumar Jairam
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Vincent Van averbeke
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Pieter Moons
3Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
Ella Roelant
4StatUa, Center for Statistics, University of Antwerp, Antwerp, B-2000, Belgium
6Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, B-2650, Belgium
Debbie Le Blon
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Wim Vanden Berghe
8PPES Lab Protein Chemistry, Proteomics & Epigenetic Signaling, IPPON, Department Biomedical Sciences, University Antwerp, Universiteitsplein 1, Wilrijk B-2610, Belgium
Annelies Janssens
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
Willem Lybaert
9Department of Medical Oncology, AZ Nikolaas, Sint-Niklaas, Belgium
Lieselot Croes
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
10Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares Ghent, Belgium
Christof Vulsteke
6Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, B-2650, Belgium
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
10Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares Ghent, Belgium
Surbhi Malhotra-Kumar
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Herman Goossens
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Zwi Berneman
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
Marc Peeters
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Peter van Dam
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Samir Kumar-Singh
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 29, 2021.
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
Fien HR De Winter, An Hotterbeekx, Manon Huizing, Angelina Konnova, Erik Fransen, Bart’s Jongers, Ravi Kumar Jairam, Vincent Van averbeke, Pieter Moons, Ella Roelant, Debbie Le Blon, Wim Vanden Berghe, Annelies Janssens, Willem Lybaert, Lieselot Croes, Christof Vulsteke, Surbhi Malhotra-Kumar, Herman Goossens, Zwi Berneman, Marc Peeters, Peter van Dam, Samir Kumar-Singh
medRxiv 2021.10.29.21265511; doi: https://doi.org/10.1101/2021.10.29.21265511
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
Fien HR De Winter, An Hotterbeekx, Manon Huizing, Angelina Konnova, Erik Fransen, Bart’s Jongers, Ravi Kumar Jairam, Vincent Van averbeke, Pieter Moons, Ella Roelant, Debbie Le Blon, Wim Vanden Berghe, Annelies Janssens, Willem Lybaert, Lieselot Croes, Christof Vulsteke, Surbhi Malhotra-Kumar, Herman Goossens, Zwi Berneman, Marc Peeters, Peter van Dam, Samir Kumar-Singh
medRxiv 2021.10.29.21265511; doi: https://doi.org/10.1101/2021.10.29.21265511
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)